FDA — authorised 12 April 1988
- Application: NDA019508
- Marketing authorisation holder: SMITHKLINE BEECHAM
- Local brand name: AXID
- Indication: CAPSULE — ORAL
- Status: approved
🇺🇸 Axid Capsule 150mg in United States
FDA authorised Axid Capsule 150mg on 12 April 1988
Marketing authorisations
FDA — authorised 25 May 2004
- Application: NDA021494
- Marketing authorisation holder: BRAINTREE
- Local brand name: AXID
- Indication: SOLUTION — ORAL
- Status: approved
FDA
- Status: approved
Axid Capsule 150mg in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is Axid Capsule 150mg approved in United States?
Yes. FDA authorised it on 12 April 1988; FDA authorised it on 25 May 2004; FDA has authorised it.
Who is the marketing authorisation holder for Axid Capsule 150mg in United States?
SMITHKLINE BEECHAM holds the US marketing authorisation.